3oof: Difference between revisions

Line 1:

'''Unreleased structure'''

The entry 3oof is ON HOLD

The entry 3oof is ON HOLD until Paper Publication

Authors: Rudolph, M.G.

Description: ~~Lead optimization~~ of ~~a novel class of benzimidazole~~-~~based farnesoid X receptor~~ (~~FXR~~) ~~agonists for improved physicochemical and ADME properties~~

Description: Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep ~~15 10~~:38:03 2010''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 22 14:33:56 2010''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
 '''Unreleased structure'''
-The entry 3oof is ON HOLD
+The entry 3oof is ON HOLD  until Paper Publication
 Authors: Rudolph, M.G.
-Description: Lead optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists for improved physicochemical and ADME properties
+Description: Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 15 10:38:03 2010''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 22 14:33:56 2010''